Financial News
Ascendis Pharma A/S - American Depositary Shares (NQ: ASND )
144.08
+1.59
(+1.12%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Ascendis Pharma A/S - American Depositary Shares
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230404006094/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20230404005510/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Ascendis Pharma
April 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230403005835/en/827144/22/Schall-Firm-Logo-640x360.jpg)
![](https://g.foolcdn.com/editorial/images/726898/crashing-arrow.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/asnd.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/image48.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via Benzinga
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/april/mmc/mmc-april3.jpg?sfvrsn=5feaab06_2)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/03/tesla_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Ascendis Pharma's Future
February 03, 2023
Via Benzinga
Where Ascendis Pharma Stands With Analysts
November 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/03/heska_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/03/stock-pharmaceutical-2-adobe.jpg)
![](https://mms.businesswire.com/media/20230403005666/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
What 9 Analyst Ratings Have To Say About Ascendis Pharma
November 29, 2022
Via Benzinga
Analyst Ratings for Ascendis Pharma
November 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image_6.png?width=1200&height=800&fit=crop)
Ascendis Pharma's Program Hits Primary Goal In Children With Short-Limbed Dwarfism
November 14, 2022
Via Benzinga
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/11/Stock-biotech-09-adobe.jpg)
![](https://www.marketbeat.com/logos/articles/small_20230220130828_johnson-johnson-taking-the-bull-by-the-horns.jpg)
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Via MarketBeat
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image-hasbro.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/15/image42.jpg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.